Welcome and Introduction
The current state of diabetes in the US and globally
A. Enrique Caballero, MD
Current approach to eye disease diagnosis and management
Paolo Silva, MD
Clinical case and Q&A session
Mid-morning break
Addressing sexual dysfunction in both men and women with diabetes
Martin N. Kathrins, MD
* NOT RECORDED
Clinical case and Q&A session
Break
Update on the diagnosis and management of diabetic neuropathy
James Russell
Clinical Case and Q&A session
Enrique Caballero + TBD
Lunch Break
Peripheral vascular disease in patients with diabetes
Allen D. Hamdan, MD
Clinical case and Q&A session
Transition Break
Key lessons during this pandemic
Nadine Palermo, MD
Q&A session
Break-out session: Key teaching points of the day
Full group debrief
Welcome
The causes and implications of hypoglycemia
Devin Steenkamp, MBChB
Educating our patients on hypoglycemia prevention and management
Charles McKitrick, RN, CDCES
Clinical case and Q&A session
Break
The clinical impact of obesity
Osama Hamdy, MD
Obesity, diabetes and cancer
Jennifer A. Ligibel, MD
Panel discussion and Q&A
Lunch Break
Lifestyle Modification
Kellene Isom
Medical Management
Scott Butsch, MD MSc FTOS
Transition Break
Surgical Management
Caroline Apovian, MD
Clinical Cases and Q&A
Break-out session: Key teaching points of the day
Full group debrief
Welcome
NASH - An update
Ken Cusi, MD
Clinical case and Q&A session
Break
Hypertension management in 2022
Naomi Fisher, MD
Dyslipidemia management update
Om Ganda, MD
Break
Clinical case and Q&A session
Comprehensive management of diabetes: Old and new approaches
Antonio Ceriello
Lunch break
Heart failure in the patient with diabetes: Practical implications
Deepak Bhatt, MD
Coronary artery disease: Diagnosis and management
Chris Cannon, MD
Break
Clinical case and Q&A session
Break-out session: Key teaching points of the day
Full group debrief
Welcome
Chronic kidney disease in diabetes
Robert Stanton, MD
Clinical case and Q&A session
Break
The role of biguanides and sulfonylureas
Enrique Caballero, MD
Is there still a role for TZDs?
Bindu Chamarti, MD, MMSc
Break
Insulin use in the setting of chronic complications
Guillermo Umpierrez, MD
Clinical case discussions and Q&A session
Lunch break
Incretin-based therapies: DPP-IV inhibitors and GLP-1 RA
Lee-Shing Chang, MD
SGLT-2 inhibitors
Mandeep Bajaj, MBBS
Break
Clinical cases and Q&A session
Break
Break-out session: Key teaching points of the day
Full group debrief
Closing remarks